Madison El-Saadi
Stock Analyst at B. Riley Securities
(4.60)
# 458
Out of 5,182 analysts
15
Total ratings
73.33%
Success rate
25.89%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Madison El-Saadi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ETON Eton Pharmaceuticals | Maintains: Buy | $26 → $31 | $23.61 | +31.30% | 4 | Mar 20, 2026 | |
| CAPR Capricor Therapeutics | Maintains: Buy | $50 → $63 | $35.00 | +80.00% | 3 | Mar 13, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $61 → $101 | $73.92 | +36.63% | 1 | Jan 22, 2026 | |
| VNDA Vanda Pharmaceuticals | Maintains: Buy | $11 → $14 | $6.83 | +104.98% | 2 | Dec 31, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $19 → $37 | $7.38 | +401.36% | 4 | Dec 12, 2025 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $179 | $186.42 | -3.98% | 1 | Oct 1, 2025 |
Eton Pharmaceuticals
Mar 20, 2026
Maintains: Buy
Price Target: $26 → $31
Current: $23.61
Upside: +31.30%
Capricor Therapeutics
Mar 13, 2026
Maintains: Buy
Price Target: $50 → $63
Current: $35.00
Upside: +80.00%
Arrowhead Pharmaceuticals
Jan 22, 2026
Maintains: Buy
Price Target: $61 → $101
Current: $73.92
Upside: +36.63%
Vanda Pharmaceuticals
Dec 31, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $6.83
Upside: +104.98%
Wave Life Sciences
Dec 12, 2025
Maintains: Buy
Price Target: $19 → $37
Current: $7.38
Upside: +401.36%
Axsome Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $179
Current: $186.42
Upside: -3.98%